Overview
Massimo Granai practices in Siena, Italy. Mr. Granai is rated as a Distinguished expert by MediFind in the treatment of Burkitt Lymphoma. His top areas of expertise are Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Appendectomy.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Burkitt Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Burkitt LymphomaMr. Granai isDistinguished. Learn about Burkitt Lymphoma.
- Advanced
- B-Cell LymphomaMr. Granai isAdvanced. Learn about B-Cell Lymphoma.
- Marginal Zone Lymphoma (MZL)Mr. Granai isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- MononucleosisMr. Granai isAdvanced. Learn about Mononucleosis.
- Non-Hodgkin LymphomaMr. Granai isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- AppendectomyMr. Granai isExperienced. Learn about Appendectomy.
- AppendicitisMr. Granai isExperienced. Learn about Appendicitis.
- Appendix CancerMr. Granai isExperienced. Learn about Appendix Cancer.
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
- Autoimmune Polyglandular Syndrome Type 2
- Chronic B-Cell Leukemia (CBCL)Mr. Granai isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).